Simbec-Orion Receives the 'CRO of the Year' Award at 2019 European Lifestars Awards

Celebrating success across life sciences
Simbec-Orion

​​​​​Simbec-Orion is pleased to announce that it has been recognised as the winner of the CRO of the Year award at the 2019 Lifestars AwardsTM.

Lifestars is a celebration of the success stories, innovations, transformational deals and the people, teams and organisations that play such a critical role in the advancement of the industry over the last 12 months across Europe. 

The international awards bring together hundreds of global life science leaders, investors and deal makers and key stakeholders from the wider ecosystem to recognise the achievements of the industry. Nineteen awards were contested during a prestigious gala dinner hosted at the Honourable Artillery Company in London, UK, on November 19. The Awards supported Teenage Cancer Trust as the official charity beneficiary.

European Lifestars AwardsTM forms a signature, evening networking function during the Investival Showcase and Jefferies Annual Healthcare Conference week in London, Europe's largest healthcare investment banking conference.

“I am absolutely honoured to accept this award on behalf of Simbec-Orion and to share it with our amazing team of clinical research professionals," Dr. Fabrice Chartier, recently appointed CEO.

“This award acknowledges the commitment we have made to structure our business to meet the needs of small and midsize drug developers, developing new therapies in rare disease and oncology.

This accolade recognizes the breadth of our full-service, which includes a dedicated clinical pharmacology group, clinical development focused on rare disease and oncology, and our laboratory services. When combined with our expertise gained from working in translational medicine and challenging therapeutic areas, we can ally with clients in the most cost-effective and flexible approach to reach their clinical and commercial milestones." -Dr. Fabrice Chartier CEO, Simbec-Orion

"Lifestars presents a fantastic opportunity to bring together a deserved audience and highlight the advances being made in our industry. It’s testament to Simbec-Orion’s efforts that this year’s judging faculty have recognized them in this manner." -Neil Darkes, Co-CEO, LSX Ltd. and Lifestars

 

About Simbec-Orion

Simbec-Orion is a full-service boutique CRO growing by bringing together the best possible people, healthcare professionals and drug developers from all areas of clinical development.

We focus on a defined series of core therapeutic areas, where we can make the best use of our skills elegantly to design, execute and deliver our clients’ clinical development needs. We are making Simbec-Orion a highly respected and profitable boutique CRO. We do this by working for our clients with excellence, commitment and passion. We provide an environment in which our colleagues can continue to grow and develop.

We will always remember that our work leads to the improvement of patients’ lives.

About LifestarsTM

The LifestarsTM Awards are organised by LSX, an influential community of senior life science decision-makers. Through impactful events, powerful thought leadership content and unique networking opportunities, LSX exists to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal-making in healthcare. For more information, please visit www.lsxleaders.com/lifestars-awards.

 

END

Contact: Eleni Elia Noothen

Phone: +44 (0)1753 695154

Email: [email protected]

Contact: Neil Darkes
Phone: +44 (0) 203 637 5908
Email: [email protected]   

Source: Simbec-Orion

Share:


Tags: biotech, clinical research, CRO, oncology, rare disease


About Simbec-Orion

View Website

Simbec-Orion is a responsive and agile full-service CRO, with wide therapeutic experience and specialist expertise in clinical pharmacology, oncology and rare diseases.

Simbec-Orion
7 Bath Rd
Slough
SL1 3UA
United Kingdom